Article Information
- Received August 20, 2012
- Revision received February 18, 2013
- Accepted February 27, 2013
- First published April 17, 2013.
- Version of record published April 17, 2013.
Author Information
- Arie Reijerkerk1,*,
- M. Alejandro Lopez-Ramirez2,*,
- Bert van het Hof1,
- Joost A.R. Drexhage1,
- Wouter W. Kamphuis1,
- Gijs Kooij1,
- Joost B. Vos3,
- Tineke C.T.M. van der Pouw Kraan3,
- Anton J. van Zonneveld4,
- Anton J. Horrevoets3,
- Alexandre Prat5,
- Ignacio A. Romero2,†, and
- Helga E. de Vries1,†
- 1Blood–Brain Barrier Research Group, Molecular Cell Biology and Immunology, Neuroscience Campus Amsterdam, VU University Medical Center, 1007 MB Amsterdam, The Netherlands,
- 2Department of Life, Health & Chemical Sciences, The Open University, Milton Keynes MK7 6AA, United Kingdom,
- 3Molecular Cell Biology and Immunology, VU University Medical Center, 1007 MB Amsterdam, The Netherlands,
- 4Department of Nephrology and Einthoven Laboratory for Experimental Vascular Research, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands, and
- 5Neuroimmunology Research Laboratory, Centre of Excellence in Neuromics, CHUM-Notre-Dame Hospital, Faculty of Medicine, Université de Montréal, Montréal, Quebec H2L 4M1, Canada
Author contributions
Author contributions: A.R., I.A.R., and H.E.d.V. designed research; A.R., M.A.L.-R., B.v.h.H., J.A.R.D., W.K., G.K., and J.B.V. performed research; A.P. contributed unpublished reagents/analytic tools; A.R., M.A.L.-R., J.B.V., T.C.T.M.v.d.P.K., A.J.v.Z., and A.J.H. analyzed data; A.R. and H.E.d.V. wrote the paper.
↵*A.R. and M.A.L.-R. contributed equally to this work.
↵†I.A.R. and H.E.d.V. contributed equally to this work.
Disclosures
- Received August 20, 2012.
- Revision received February 18, 2013.
- Accepted February 27, 2013.
This work was supported by grants from the Netherlands Genomics Initiative (A.R., J.A.R.D.), the MS Research Foundation (A.R. and H.E.d.V., Grant 08-642), ZonMw [J.B.V.; DPTE (Dutch Program Tissue Engineering) Grant LGT.6918], and Multiple Sclerosis Society of Great Britain and Northern Ireland (I.A.R.). The funders had no role in study design, data collection, and analysis; decision to publish; or preparation of the manuscript.
The authors declare no competing financial interests.
- Correspondence should be addressed to either of the following: Helga E. de Vries, Blood–Brain Barrier Research Group, Molecular Cell Biology and Immunology, VU University Medical Center, PO Box 7057, 1007 MB Amsterdam, The Netherlands, he.devries{at}vumc.nl; or Ignacio A. Romero, Department of Life, Health & Chemical Sciences, The Open University, Milton Keynes MK7 6AA, United Kingdom. i.romero{at}open.ac.uk
